Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Total Stockholders Equity : ¥1,493.7 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Total Stockholders Equity?

Anhui Wanbang Pharmaceutical Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,493.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Anhui Wanbang Pharmaceutical Technology Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥22.41. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Anhui Wanbang Pharmaceutical Technology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Anhui Wanbang Pharmaceutical Technology Co Total Stockholders Equity Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Total Stockholders Equity Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

52.86

151.01

232.88

331.62

1,464.01

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial									356.60	385.44	1,433.23	1,464.01	1,493.70

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Anhui Wanbang Pharmaceutical Technology Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1493.697	-	0)	/	66.6667
	=	22.41

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Anhui Wanbang Pharmaceutical Technology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	1493.697
	=	0.00

Anhui Wanbang Pharmaceutical Technology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Anhui Wanbang Pharmaceutical Technology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000

Website

http://www.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines